CCCC - C4 Therapeutics  - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart Insider Trading

CCCC is currently covered by 11 analysts with an average price target of $20.58. This is a potential upside of $12.53 (155.65%) from yesterday's end of day stock price of $8.05.

C4 Therapeutics 's activity chart (see below) currently has 16 price targets and 39 ratings on display. The stock rating distribution of CCCC is 42.86% BUY, 17.86% SELL and 39.29% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 37.77% with an average time for these price targets to be met of 45.64 days.

Highest price target for CCCC is $15, Lowest price target is $6, average price target is $20.58.

Most recent stock forecast was given by TERENCE FLYNN from MORGAN STANLEY on 26-Feb-2024. First documented stock forecast 27-Oct-2020.

Currently out of the existing stock ratings of CCCC, 12 are a BUY (42.86%), 5 are a SELL (17.86%), 11 are a HOLD (39.29%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

8

$-0.05 (-0.62%)

3

1 months 2 days ago

4/4 (100%)

$-1.51 (-15.88%)

39

Buy

13

$4.95 (61.49%)

12

1 months 5 days ago

4/7 (57.14%)

$4.01 (44.61%)

102

Hold

6

$-2.05 (-25.47%)

5

1 months 28 days ago

2/4 (50%)

$-0.33 (-5.21%)

7

Buy

7

$-1.05 (-13.04%)

17

4 months 26 days ago

1/4 (25%)

$5.6 (400.00%)

68

Buy

20

4 months 26 days ago

0/1 (0%)

$11.99 (149.69%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is CCCC (C4 Therapeutics ) average time for price targets to be met?

On average it took 45.64 days on average for the stock forecasts to be realized with a an average price target met ratio 37.77

Which analyst has the current highest performing score on CCCC (C4 Therapeutics ) with a proven track record?

DEREK ARCHILA

Which analyst has the most public recommendations on CCCC (C4 Therapeutics )?

Derek Archila works at WELLS FARGO and has 3 price targets and 2 ratings on CCCC

Which analyst is the currently most bullish on CCCC (C4 Therapeutics )?

Matthew Luchini with highest potential upside - $112.14

Which analyst is the currently most reserved on CCCC (C4 Therapeutics )?

Eric Joseph with lowest potential downside - -$2.05

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?